Target intelligence / Profile preview

Pericyte (brain)

Molecular classification
Other, Contractile cell, Mural cell
01

Overview

Pericytes are contractile mural cells wrapped around the microvessels of the brain, critical for regulating cerebral blood flow, stabilizing developing blood vessels, and maintaining the blood–brain barrier. Their contractility is mediated by actin–myosin machinery, with α-smooth muscle actin and myosin II as key proteins, and is regulated by diverse extracellular signals including neurotransmitters, endothelin, prostaglandins, and nitric oxide. Rather than a specific molecular target, "brain pericyte contractility" is a function supported by multiple cellular pathways and protein complexes. The relevance to disease and therapy arises from pericytes’ roles in microvascular blood flow regulation, neurovascular coupling, and blood–brain barrier integrity—impaired pericyte function contributes to neurodegeneration, vascular dementia, stroke, and blood–brain barrier dysfunction. As such, drug targeting focuses on molecular modulators of pericyte contraction/relaxation, not the contractile machinery itself.

Other names
Perivascular cell (brain)Rouget cell (historical)Neurovascular unit pericyte
02

Mechanism of action

Alteration of pericyte contraction or relaxation via modulation of intracellular calcium, various signaling pathways (endothelin, adenosine, prostaglandin, nitric oxide, Rho kinase, PDGF)

03

Biological functions

Regulation of cerebral blood flowBlood–brain barrier maintenanceVascular development and maintenanceNeurovascular coupling (linking neuronal activity to blood flow)Regulation of immune cell entry into the central nervous system
04

Disease associations

Neurodegenerative disease (e.g., Alzheimer’s disease)Stroke/ischemiaBlood–brain barrier breakdownOther vascular and CNS diseases
05

Safety considerations

Targeting pericyte contractility could affect cerebral blood flow homeostasis, risking ischemia or excessive leakage across the blood–brain barrierPotential for exacerbating neurovascular unit dysfunction and causing neuron damage
06

Interacting drugs

Endothelin receptor antagonists (experimental/preclinical)

3 more in the full profile.

07

Biomarkers

PDGFRβ (Platelet-derived growth factor receptor beta)α-SMA (alpha-smooth muscle actin)NG2 (Neuron-glial antigen 2)CD13DesminVimentin

Beyond the preview

Go deeper on Pericyte (brain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pericyte (brain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call